By the seems of it, we’re about to face one of the crucial aggressive vaccine campaigns ever created. According to Reuters,1 the U.S. authorities is planning to launch an “overwhelming” COVID-19 vaccine marketing campaign come November, supplied the U.S. Food and Drug Administration provides a number of vaccine candidates the inexperienced mild.
Considering former FDA commissioner Dr. Scott Gottlieb2 is now on Pfizer’s board of administrators,3 and Pfizer’s COVID-19 vaccine is without doubt one of the lead candidates, jaded minds would possibly assume the FDA is not going to place up any important roadblocks.
According to Reuters, the COVID-19 vaccine marketing campaign “will seemingly be compressed into a brief time period, round 4 to 6 weeks, to remove any lag between when Americans are alerted to the vaccine after which they will get vaccinated.” An unnamed “senior White House administration official” is quoted saying:4
“The superb line we’re strolling is getting the American folks very enthusiastic about vaccines and lacking expectations versus having a bunch of vaccines within the warehouse and never as many individuals wish to get it. You might not hear loads about selling vaccines over the airwaves in August and September however you will be overwhelmed by it come November.”
It’s nonetheless unclear precisely when a vaccine can be accessible, however it may very well be as early as October, or as late as January 2021. According to the administration official, the promoting marketing campaign for the vaccine can be tailor-made to particular subsets of the inhabitants, relying on the folks the vaccine is more likely to profit probably the most. Such particulars are anticipated to be teased out throughout ongoing scientific trials.